To further confirm these findings and reveal clinical significance, we also performed GSEA on the RNA-seq data of prostate cancer patients obtained from the TCGA database with the patients separated into NURR1-High and Low groups based on their ranked expression levels of NURR1. Here, NR4A2 is linked to prostate carcinoma.